Yao X L, Cowan M J, Gladwin M T, Lawrence M M, Angus C W, Shelhamer J H
Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Biol Chem. 1999 Jun 11;274(24):17202-8. doi: 10.1074/jbc.274.24.17202.
The effect of the glucocorticosteroid, dexamethasone, on arachidonic acid (AA) release and on protein levels of p11 and cytosolic phospholipase A2 (cPLA2) was studied in two epithelial cell lines, HeLa cells and BEAS-2B cells. Dexamethasone treatment of HeLa cells and BEAS-2B cells increased cellular p11 protein and mRNA levels in a time- and dose-dependent manner. It had little effect on levels of cPLA2 protein. In order to determine if increased p11 protein expression resulted in increased interaction between p11 and cPLA2, anti-cPLA2 antibodies were used to immunoprecipitate p11.cPLA2 complexes and Western blots of the immunoprecipitate were used to detect p11. In cells treated with dexamethasone, more p11 was detected in the anti-cPLA2 immunoprecipitate compared with control cells. Dexamethasone treatment of HeLa cells prelabeled with [3H]AA decreased the release of [3H]AA under basal conditions and after stimulation with the calcium ionophore A23187 (10(-6) M). In order to determine if altering the p11 protein levels in HeLa cells independent of glucocorticosteroid treatment could also produce an effect on [3H]AA release, cells were stably transfected with plasmids expressing either p11 antisense mRNA or p11 mRNA. Cloned HeLa cells expressing p11 antisense mRNA exhibited less cellular p11 protein compared with control cells and greater [3H]AA release compared with cells transfected with a control vector. Cloned HeLa cells stably transfected with a p11 expression vector exhibited increased p11 cellular protein and diminished [3H]AA release under basal conditions and in response to A23187. Therefore, dexamethasone alteration of epithelial cell AA release may be due in part to induction of p11 protein expression.
在两种上皮细胞系,即HeLa细胞和BEAS-2B细胞中,研究了糖皮质激素地塞米松对花生四烯酸(AA)释放以及p11和胞质磷脂酶A2(cPLA2)蛋白水平的影响。用地塞米松处理HeLa细胞和BEAS-2B细胞,可使细胞p11蛋白和mRNA水平呈时间和剂量依赖性增加。它对cPLA2蛋白水平影响很小。为了确定p11蛋白表达增加是否导致p11与cPLA2之间的相互作用增强,使用抗cPLA2抗体免疫沉淀p11·cPLA2复合物,并通过免疫沉淀物的蛋白质印迹法检测p11。与对照细胞相比,在用糖皮质激素处理的细胞中,抗cPLA2免疫沉淀物中检测到更多的p11。用地塞米松处理预先用[3H]AA标记的HeLa细胞,可降低基础条件下以及用钙离子载体A23187(10(-6) M)刺激后的[3H]AA释放。为了确定在不依赖糖皮质激素处理的情况下改变HeLa细胞中的p11蛋白水平是否也会对[3H]AA释放产生影响,用表达p11反义mRNA或p11 mRNA的质粒稳定转染细胞。与对照细胞相比,表达p11反义mRNA的克隆HeLa细胞显示细胞p11蛋白较少,与用对照载体转染的细胞相比,[3H]AA释放较多。用p11表达载体稳定转染的克隆HeLa细胞在基础条件下以及对A23187的反应中显示p11细胞蛋白增加,[3H]AA释放减少。因此,地塞米松对上皮细胞AA释放的改变可能部分归因于p11蛋白表达的诱导。